|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Methods |





* Division of Clinical Preventive Medicine, Department of Community Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences, Asahimachi 1-757, Niigata, Niigata 951-8510, Japan
Daiichi Pure Chemicals, Diagnostics Research Laboratories, Tokai Research Group, Muramatsu 2117, Tokai, Ibaraki 319-1182, Japan
Division of Endocrinology and Metabolism, Department of Homeostatic Regulation and Developments, Niigata University Graduate School of Medical and Dental Sciences, Asahimachi 1-757, Niigata, Niigata 951-8510, Japan
1 To whom correspondence should be addressed. e-mail: miida{at}med.niigata-u.ac.jp
We have established an immunoassay for preß1-HDL (the initial acceptor of cellular cholesterol) using a monoclonal antibody, MAb55201. Because preß1-HDL is unstable during storage, fresh plasma must be used for preß1-HDL measurements. In this study, we describe a method of stabilizing preß1-HDL, and evaluate the analytical performance of the immunoassay for preß1-HDL. Fresh plasma was stored under various conditions with or without a pretreatment consisting of a 21-fold dilution into 50% (v/v) sucrose. Preß1-HDL concentration was measured by immunoassay. In nonpretreated samples, preß1-HDL decreased significantly from the baseline after 6 h at room temperature. Although preß1-HDL was more stable at 0°C than at room temperature, it increased from 30.2 ± 8.5 (SE) to 56.5 ± 5.5 mg/l apolipoprotein A-I (apoA-I) (P < 0.001) in hyperlipidemics, and from 18.4 ± 1.2 to 37.9 ± 3.3 mg/l apoA-I (P < 0.001) in normolipidemics after 5-day storage. After 30-day storage at -80°C, preß1-HDL increased from 29.0 ± 4.0 to 38.0 ± 5.7 mg/l apoA-I (P < 0.001) in hyperlipidemics, whereas it did not change in normolipidemics. In pretreated samples, preß1-HDL concentration did not change significantly under any of the above conditions. Moreover, preß1-HDL concentrations determined by immunoassay correlated with those determined by native two-dimensional gel electrophoresis (n = 24, r = 0.833, P < 0.05).
An immunoassay using MAb55201 with pretreated plasma is useful for clinical measurement of preß1-HDL.
Abbreviations: 2D-gel, two-dimensional gel; DTNB, 5,5'-dithio-bis(2-nitrobenzoic acid)
Supplementary key words hyperlipidemia lecithin:cholesterol acyltransferase apolipoprotein A-I two-dimensional gel electrophoresis
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. S. Troutt, W. E. Alborn, M. K. Mosior, J. Dai, A. T. Murphy, T. P. Beyer, Y. Zhang, G. Cao, and R. J. Konrad An apolipoprotein A-I mimetic dose-dependently increases the formation of pre{beta}1 HDL in human plasma J. Lipid Res., March 1, 2008; 49(3): 581 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hirayama, T. Miida, O. Miyazaki, and Y. Aizawa Pre{beta}1-HDL Concentration Is a Predictor of Carotid Atherosclerosis in Type 2 Diabetic Patients Diabetes Care, May 1, 2007; 30(5): 1289 - 1291. [Full Text] [PDF] |
||||
![]() |
S. Soderlund, A. Soro-Paavonen, C. Ehnholm, M. Jauhiainen, and M.-R. Taskinen Hypertriglyceridemia is associated with pre{beta}-HDL concentrations in subjects with familial low HDL J. Lipid Res., August 1, 2005; 46(8): 1643 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzuki, H. Wada, S. Maeda, K. Saito, S. Minatoguchi, K. Saito, and M. Seishima Increased Plasma Lipid-Poor Apolipoprotein A-I in Patients with Coronary Artery Disease Clin. Chem., January 1, 2005; 51(1): 132 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Olchawa, B. A. Kingwell, A. Hoang, L. Schneider, O. Miyazaki, P. Nestel, and D. Sviridov Physical Fitness and Reverse Cholesterol Transport Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1087 - 1091. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |